115 related articles for article (PubMed ID: 38142011)
1. Acrolein suppresses anticancer drug-induced toxicity mediated by activating claudin-1 and Nrf2 axis in a spheroid model of human lung squamous cell carcinoma cells.
Eguchi H; Yu Y; Matsunaga T; Yoshino Y; Ikari A
Toxicol Lett; 2024 Feb; 392():46-55. PubMed ID: 38142011
[TBL] [Abstract][Full Text] [Related]
2. Chrysin enhances anticancer drug-induced toxicity mediated by the reduction of claudin-1 and 11 expression in a spheroid culture model of lung squamous cell carcinoma cells.
Maruhashi R; Eguchi H; Akizuki R; Hamada S; Furuta T; Matsunaga T; Endo S; Ichihara K; Ikari A
Sci Rep; 2019 Sep; 9(1):13753. PubMed ID: 31551535
[TBL] [Abstract][Full Text] [Related]
3. Decrease in paracellular permeability and chemosensitivity to doxorubicin by claudin-1 in spheroid culture models of human lung adenocarcinoma A549 cells.
Akizuki R; Maruhashi R; Eguchi H; Kitabatake K; Tsukimoto M; Furuta T; Matsunaga T; Endo S; Ikari A
Biochim Biophys Acta Mol Cell Res; 2018 May; 1865(5):769-780. PubMed ID: 29524521
[TBL] [Abstract][Full Text] [Related]
4. Increase in Toxicity of Anticancer Drugs by PMTPV, a Claudin-1-Binding Peptide, Mediated via Down-Regulation of Claudin-1 in Human Lung Adenocarcinoma A549 Cells.
Nasako H; Takashina Y; Eguchi H; Ito A; Ishikawa Y; Matsunaga T; Endo S; Ikari A
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824620
[TBL] [Abstract][Full Text] [Related]
5. Elevation of Anticancer Drug Toxicity by Caffeine in Spheroid Model of Human Lung Adenocarcinoma A549 Cells Mediated by Reduction in Claudin-2 and Nrf2 Expression.
Eguchi H; Kimura R; Onuma S; Ito A; Yu Y; Yoshino Y; Matsunaga T; Endo S; Ikari A
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555089
[TBL] [Abstract][Full Text] [Related]
6. Claudin-1 Protein Expression Is a Good Prognostic Factor in Non-Small Cell Lung Cancer, but only in Squamous Cell Carcinoma Cases.
Moldvay J; Fábián K; Jäckel M; Németh Z; Bogos K; Furák J; Tiszlavicz L; Fillinger J; Döme B; Schaff Z
Pathol Oncol Res; 2017 Jan; 23(1):151-156. PubMed ID: 27687058
[TBL] [Abstract][Full Text] [Related]
7. Activation of the TGF-β1/EMT signaling pathway by claudin-1 overexpression reduces doxorubicin sensitivity in small cell lung cancer SBC-3 cells.
Nagaoka Y; Oshiro K; Yoshino Y; Matsunaga T; Endo S; Ikari A
Arch Biochem Biophys; 2024 Jan; 751():109824. PubMed ID: 37984759
[TBL] [Abstract][Full Text] [Related]
8. CLDN1 Increases Drug Resistance of Non-Small Cell Lung Cancer by Activating Autophagy via Up-Regulation of ULK1 Phosphorylation.
Zhao Z; Li J; Jiang Y; Xu W; Li X; Jing W
Med Sci Monit; 2017 Jun; 23():2906-2916. PubMed ID: 28614291
[TBL] [Abstract][Full Text] [Related]
9. PKCδ-iPLA2-PGE2-PPARγ signaling cascade mediates TNF-α induced Claudin 1 expression in human lung carcinoma cells.
Iitaka D; Moodley S; Shimizu H; Bai XH; Liu M
Cell Signal; 2015 Mar; 27(3):568-77. PubMed ID: 25562426
[TBL] [Abstract][Full Text] [Related]
10. IL-33 down-regulates CLDN1 expression through the ERK/STAT3 pathway in keratinocytes.
Ryu WI; Lee H; Bae HC; Jeon J; Ryu HJ; Kim J; Kim JH; Son JW; Kim J; Imai Y; Yamanishi K; Jeong SH; Son SW
J Dermatol Sci; 2018 Jun; 90(3):313-322. PubMed ID: 29534857
[TBL] [Abstract][Full Text] [Related]
11. Withaferin A mitigates metastatic traits in human oral squamous cell carcinoma caused by aberrant claudin-1 expression.
Shin JA; Kim LH; Ryu MH; Choi SY; Jin B; Lee W; Jung YC; Ahn CH; Ahn MH; Hong KO; Swarup N; Chawla K; Kang SC; Hong SD; Cho SD
Cell Biol Toxicol; 2022 Feb; 38(1):147-165. PubMed ID: 33665778
[TBL] [Abstract][Full Text] [Related]
12. CLDN1 induces autophagy to promote proliferation and metastasis of esophageal squamous carcinoma through AMPK/STAT1/ULK1 signaling.
Wu J; Gao F; Xu T; Li J; Hu Z; Wang C; Long Y; He X; Deng X; Ren D; Zhou B; Dai T
J Cell Physiol; 2020 Mar; 235(3):2245-2259. PubMed ID: 31498437
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation maintains the CLDN1-EPHB6-SLUG axis to enhance chemotherapeutic efficacy and inhibit lung cancer progression.
Wu JE; Wu YY; Tung CH; Tsai YT; Chen HY; Chen YL; Hong TM
Theranostics; 2020; 10(19):8903-8923. PubMed ID: 32754286
[TBL] [Abstract][Full Text] [Related]
14. Treatment of HCC with claudin-1-specific antibodies suppresses carcinogenic signaling and reprograms the tumor microenvironment.
Roehlen N; Muller M; Nehme Z; Crouchet E; Jühling F; Del Zompo F; Cherradi S; Duong FHT; Almeida N; Saviano A; Fernández-Vaquero M; Riedl T; El Saghire H; Durand SC; Ponsolles C; Oudot MA; Martin R; Brignon N; Felli E; Pessaux P; Lallement A; Davidson I; Bandiera S; Thumann C; Marchand P; Moll S; Nicolay B; Bardeesy N; Hoshida Y; Heikenwälder M; Iacone R; Toso A; Meyer M; Elson G; Schweighoffer T; Teixeira G; Zeisel MB; Laquerriere P; Lupberger J; Schuster C; Mailly L; Baumert TF
J Hepatol; 2023 Feb; 78(2):343-355. PubMed ID: 36309131
[TBL] [Abstract][Full Text] [Related]
15. Claudin-1 mediates progression by regulating EMT through AMPK/TGF-β signaling in head and neck squamous cell carcinoma.
Chang JW; Seo ST; Im MA; Won HR; Liu L; Oh C; Jin YL; Piao Y; Kim HJ; Kim JT; Jung SN; Koo BS
Transl Res; 2022 Sep; 247():58-78. PubMed ID: 35462077
[TBL] [Abstract][Full Text] [Related]
16. Brazilian Green Propolis Rescues Oxidative Stress-Induced Mislocalization of Claudin-1 in Human Keratinocyte-Derived HaCaT Cells.
Marunaka K; Kobayashi M; Shu S; Matsunaga T; Ikari A
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31398894
[TBL] [Abstract][Full Text] [Related]
17. Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer.
Yoda S; Soejima K; Hamamoto J; Yasuda H; Nakayama S; Satomi R; Terai H; Ikemura S; Sato T; Naoki K; Betsuyaku T
Lung Cancer; 2014 Sep; 85(3):366-72. PubMed ID: 25001509
[TBL] [Abstract][Full Text] [Related]
18. Elevation of Chemosensitivity of Lung Adenocarcinoma A549 Spheroid Cells by Claudin-2 Knockdown through Activation of Glucose Transport and Inhibition of Nrf2 Signal.
Ito A; Nasako H; Akizuki R; Takashina Y; Eguchi H; Matsunaga T; Yoshino Y; Endo S; Ikari A
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34205320
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
[TBL] [Abstract][Full Text] [Related]
20. Claudin-1 induces epithelial-mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells.
Suh Y; Yoon CH; Kim RK; Lim EJ; Oh YS; Hwang SG; An S; Yoon G; Gye MC; Yi JM; Kim MJ; Lee SJ
Oncogene; 2013 Oct; 32(41):4873-82. PubMed ID: 23160379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
